Cervical Applicators

Literature Library

Clinical Data



Contact Us

Sales & Services

+1 877 963 8327 toll free

With the Axxent® Cervical Applicators1 enable radiation oncologists to treat cervical cancer with the Xoft® Electronic Brachytherapy (eBx®) System®. The cervical applicator complements Xoft’s Axxent Vaginal Applicators for endometrial cancer treatment, allowing Xoft to now offer a range of gynecological cancer treatment options.

Benefits of cervical cancer treatment with the Xoft System include:

  • No radioactive isotopes
  • Minimal room shielding requirements
  • Point A coverage
  • Lower dose to critical structures
  • Patient transport to treatment vault not required after imaging
  • System portability
  • Two different angled Colpostat sets to accommodate female anatomy
  • CT compatibility and MR conditional       2

Design and Dosimetry

The Xoft cervical applicators were designed to maintain dose coverage to Point A by using titanium in the applicator walls to filter out low-energy radiation from the source. Dose volume histograms confirm that the Xoft 50 kV source has comparable PTV coverage to Ir-192, with lower dose to critical structures.


  1. FDA cleared for HDR brachytherapy for intracavitary treatment of cancer of the uterus, cervix, endometrium and vagina.
  2. MR Conditional: an item that has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use (specified in the Instructions for Use manual).

©2017 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.